Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRA · BSE: 540788 · Healthcare · 31 announcements

Share price
₹119.15
Market cap
₹122.6 Cr
Revenue (annual)
₹24.98 Cr
Net profit (annual)
₹0.05 Cr
P/E (TTM)
-271.0×Sector 53.1×
Promoter holding
46.58%+28.19% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:45 IST BSE
Board Meeting Date

Aspira Pathlab & Diagnostics Board Meeting Date

Aspira Pathlab will hold a board meeting on 12 Sep 2026 to consider a capital raise via preferential issue, private placement, or rights issue. No amount or terms are yet specified.

15:30 IST BSE
Board Meeting Date

Aspira Pathlab & Diagnostics Board Meeting Date

Aspira Pathlab & Diagnostics will hold a board meeting on August 12, 2026, to approve its Q1 financial results and discuss a potential fund-raising proposal.

20:16 IST BSE
Board Meeting Date

Aspira Pathlab & Diagnostics Board Meeting Date

Aspira Pathlab & Diagnostics scheduled a board meeting on May 23, 2026. Directors will consider audited financial results for the quarter and year ended March 2026.